{
    "clinical_study": {
        "@rank": "154795", 
        "arm_group": [
            {
                "arm_group_label": "Epidural Technique", 
                "arm_group_type": "Active Comparator", 
                "description": "Bupivacaine 0.125% with Fentanyl 2 mcg/mL, 15 mL load over 5 min"
            }, 
            {
                "arm_group_label": "Combined Spinal Epidural Technique", 
                "arm_group_type": "Active Comparator", 
                "description": "Bupivacaine 2.5 mg with Fentanyl 25 mcg"
            }, 
            {
                "arm_group_label": "Dural Puncture Epidural Technique", 
                "arm_group_type": "Active Comparator", 
                "description": "Bupivacaine 0.125% with Fentanyl 2 mcg/mL, 15 mL load over 5 min"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of this study is to compare the onset and duration of the initial dose\n      of medications given through three different epidural (conventional epidural, combined\n      spinal epidural and dural puncture epidural) techniques for labor pain relief.\n\n      The secondary objective of this study is to compare the fetal effects of these three\n      epidural labor analgesia techniques."
        }, 
        "brief_title": "Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes", 
        "condition": "Laboring Women Requesting Neuraxial Labor Analgesia", 
        "condition_browse": {
            "mesh_term": "Labor Pain"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1. Nulliparous (first baby) parturient 2. Singleton, vertex gestation at term (37-42\n             weeks) 3. Less than 5 cm dilation 4. Desires an epidural technique for labor\n             analgesia\n\n        Exclusion Criteria:\n\n        - 1. Current or historical evidence of clinically significant disease or condition,\n        including diseases of pregnancy (i.e preeclampsia, gestational diabetes) 2. Any\n        contraindication to the administration of an epidural technique 3. History of\n        hypersensitivity or idiosyncratic reaction to local anesthetic or opioid medications 4.\n        Current or historical evidence of a disease which may result in the risk of a cesarean\n        delivery.\n\n        5. Evidence of anticipated fetal anomalies"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02008591", 
            "org_study_id": "2013P001927"
        }, 
        "intervention": {
            "arm_group_label": [
                "Epidural Technique", 
                "Combined Spinal Epidural Technique", 
                "Dural Puncture Epidural Technique"
            ], 
            "description": "Three different techniques, using the same medications (bupivacaine and fentanyl)", 
            "intervention_name": "Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Neuraxial Technique", 
            "Epidural Technique", 
            "Dural Puncture Epidural Technique", 
            "Combined Spinal Epidural Technique", 
            "Labor Analgesia", 
            "Obstetric"
        ], 
        "lastchanged_date": "December 6, 2013", 
        "location": {
            "contact": {
                "email": "ltsen@zeus.bwh.harvard.edu", 
                "last_name": "Lawrence C Tsen, MD", 
                "phone": "617-732-8216"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Brigham and Women's Hospital"
            }, 
            "investigator": {
                "last_name": "Lawrence C Tsen, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes", 
        "overall_official": {
            "affiliation": "Brigham and Women's Hospital", 
            "last_name": "Lawrence C Tsen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Onset, quality, and duration of analgesia, occurrences of hypotension, bradycardia, pruritus, nausea, emesis.", 
            "measure": "Maternal Outcomes", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02008591"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brigham and Women's Hospital", 
            "investigator_full_name": "Lawrence Ching Tsen", 
            "investigator_title": "Associate Professor, Harvard Medical School", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Occurrence of fetal bradycardia or other heart rate changes, changes in fetal heart tracing patterns", 
            "measure": "Fetal Outcomes", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours"
        }, 
        "source": "Brigham and Women's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}